Several distinct fluid flow phenomena occur in solid tumors, including intravascular blood flow and interstitial convection. Interstitial fluid pressure is often raised in solid tumors, which can limit drug delivery. To probe low-velocity flow in tumors resulting from raised interstitial fluid pressure, we developed a novel magnetic resonance imaging (MRI) technique named convection-MRI, which uses a phase-contrast acquisition with a dual-inversion vascular nulling preparation to separate intra-and extra-vascular flow. Here we report the results of experiments in flow phantoms, numerical simulations, and tumor xenograft models to investigate the technical feasibility of convection-MRI. We observed a significant correlation between estimates of effective fluid pressure from convection-MRI with gold-standard, invasive measurements of interstitial fluid pressure in mouse models of human colorectal carcinoma. Our results show how convection-MRI can provide insights into the growth and responsiveness to vascular-targeting therapy in colorectal cancers.
Introduction
The convection of fluid in biological tissue is normally associated with intravascular blood flow, in which fluid flows from high to lower pressure, at velocities ranging from 5 -70 cm s -1 in arteries (1,2), 0.8-2.5 mm s -1 in capillaries (3) and 1.5 -28 cm s -1 in veins (1, 2) . Fluid within the interstitium is normally maintained at or just below atmospheric pressure by venous and lymphatic vessels (4) , and several pathological conditions, including cancer, can disrupt key pressure regulation processes, leading to widespread elevated interstitial fluid pressure (IFP) (5) .
Raised IFP in solid tumors has been the subject of extensive research to investigate its pathophysiological consequences, which can include an increased metastatic potential (6-8),
higher rates of proliferation (9, 10) and impaired drug delivery (11) (12) (13) (14) (15) (16) . It is associated with numerous pathophysiological processes in tumors, and has been described as a 'universal generic early-response marker of tumor response to therapy' (17) . A physical consequence of raised IFP in tumors is the slow convection of fluid through the interstitium (4), which has been widely reported and studied (4, (18) (19) (20) (21) , but is technically challenging to measure, and has only been directly assessed through invasive means (22) . IFP is normally elevated in the center of tumors and maintained close to atmospheric pressure at the periphery by surrounding tissues, resulting in the convection of fluid from the center outwards (21) , with a velocity in the range 0.1 to 50 µm s -1 (18) .
In this study, we report the development of a new, non-invasive imaging technique that aims to probe the slower-flowing components of fluid flow in tumors; in particular, those associated with interstitial fluid. It is based on velocity-encoded MRI, with a dual inversion preparation that aims to null the faster-flowing vascular signal. We describe our approach in this study, which we have named convection-MRI, assess its technical feasibility and evaluate its underlying assumptions. Specifically, convection-MRI assumes that: 1) the intravascular signal can be completely nulled by dual inversion pulses; 2) velocity encoding is sufficiently sensitive to measure the velocity of fluid flow in the interstitium; and 3) the influence of nulled fluid exchanging between intra-and extra-vascular compartments is negligible. The physical principles underlying the acquisition are described schematically in Supplemental Movie 1. Both the dual inversion and velocity-encoding techniques have been used separately in other contexts (for example, references (23) (24) (25) for the dual inversion preparation and references (26, 27) for velocity-encoding), but their combined use is novel in the current application, and neither has been used to study interstitial flow.
The study was undertaken in two distinct mouse xenograft models of colorectal cancer, both during their growth and following treatment with a vascular disrupting agent (VDA). The results of this multiparametric, noninvasive MRI analysis allowed numerous novel insights into the differential growth characteristics of two colorectal cell lines with differing vascular and cellular morphology (SW1222 and LS174T) to be gleaned, and how these relationships were modified with VDA therapy. SW1222 cells form well-differentiated tumors with glandular structures resembling normal colon, and are well-vascularized (28) , with minimal hypoxia (29, 30) . In contrast, LS174T tumors are poorly differentiated, with heterogeneously distributed vasculature (including avascular regions) (28) , and regional hypoxia (29, 30) , and so provide a useful comparative model system.
Materials and Methods

Convection-MRI
A sequence diagram for the convection-MRI sequence is shown in Supplemental Figure 1 , which was implemented on a 9.4 T horizontal bore MRI scanner (Agilent, Santa Clara, California), with a maximum gradient strength of 1 T m -1 . The sequence consisted of two modules: a dual inversion-recovery preparation that aimed to null the signal from flowing blood, followed by velocity-encoding. The first adiabatic inversion pulse in the vascular nulling preparation was applied globally and was followed immediately by a slice-selective inversion (thickness 0.3 cm). Inversion pulses were 2 ms in duration, and were separated by 4 μs. A T 1,blood of 1900 ms was assumed, which was taken from previous measurement in the mouse ventricular pool (31) . At a time t rec following the global inversion pulse, the signal from fluid in blood vessels passes a null point, where t rec = ln(2)T 1,blood (giving t rec = 1317 ms for the value of T 1,blood used here).
Following t rec , a standard single-slice gradient echo readout sequence was applied (TE, 2.6 ms; TR, 2500 ms; flip angle, 30; slice thickness, 1 mm; field of view, 3535 mm 2 , matrix size, 128128). The v enc parameter is the maximum velocity that can be measured without producing phase aliasing, and depends on the amplitude and duration of velocity encoding gradients (32) . In this study we used gradient amplitude (G) of 300 mT m -1 and gradient duration () of 3 ms to give a v enc of 2200 μm s -1
. Velocity-encoding required two repetitions of the sequence, the second of which used bipolar gradients of opposite polarity to the first.
The difference in the phase shift induced by the gradients, between the two measurements, ϕ, is proportional to fluid velocity, according to the following relationship:
v   .
[1]
Here, v is fluid velocity, γ is the proton gyromagnetic ratio (267.513  10 6 rad s -1 T -1 ) and M 1 is the difference in first order velocity-encoding gradient moments (where v enc = π/γ M 1 and
The convection-MRI sequence was used to measure fluid velocities in two directions, corresponding to phase and readout imaging gradient orientations. Total scan duration was 25 minutes. In-plane fluid velocity vectors were constructed for each pixel and displayed using in-house software written in Interactive Data Language (ITT, Boulder, Colorado). A streamlining algorithm (iVector) was used to visualise pathways between neighbouring velocity vectors, which used points with low velocity relative to the distribution within the image as seed points.
Mouse tumor models and in vivo MRI
All in vivo experiments were approved by a local ethical review panel and the UK Home
Office Animals Scientific Procedures Act (1986), and were undertaken in accordance with UK National Cancer Research Institute (NCRI) guidelines (33) . Six-week old MF1 nu/nu mice were injected subcutaneously on the midline of the right flank, close to the hind limb (to minimize respiration motion during imaging), with 510 6 SW1222 or LS174T cells.
MRI was performed following 10 to 15 days' growth (giving a tumor volume of approximately 0.6 cm 3 ). Immediately prior to scanning, anesthesia was induced in the mice with 3-4% isoflurane carried in O 2 . Once anaesthesia was confirmed, mice were transferred to a bespoke imaging cradle, in which anesthesia was maintained with 1.25 to 1.75% isoflurane, which was delivered via a nose cone. Mice were positioned on their side, with tumor uppermost. Tumors were liberally covered in dental paste (Charmflex, Dentkist, South Korea), to eliminate bulk motion. When set (typically taking 2-3 minutes), the dental paste held the subcutaneous tumor tissue in place via contact with the imaging cradle. Once prepared, the cradle was positioned in the center of the 9.4T MRI scanner. Throughout imaging, core body temperature was monitored and maintained at 36.5 C using a warm air blower and physiological monitoring apparaturs (SA Instruments, Stony Brook, NY).
Respiratory rate was also monitored and maintained at 40 to 60 respirations per minute by varying the isoflurane fraction. RF pulses were transmitted and received with a 39 mm birdcage coil (Rapid MR International, Columbus, OH). At the end of in vivo experiments, mice were culled via cervical dislocation, and tumor tissue was harvested for further analysis.
Determining the sensitivity of convection-MRI to low-velocity flow
To evaluate the ability of the 9.4 T MRI scanner to measure the velocity of fluid travelling at velocities of the order of 1 -100 μm s -1 , an imaging phantom was constructed from a 5 mL syringe, with an internal diameter of 11 mm (see Figure 1a) . This simple phantom provided easily controllable fluid velocities, with coherent, laminar flow profiles, that can be compared against convection-MRI velocity measurements, to inform subsequent in vivo experiments. A syringe driver was used to inject water into the phantom, via silicon tubing that incorporated a 3 m loop within the scanner bore to allow the flowing water to become fully magnetised.
Convection-MRI data were acquired with no vascular nulling (i.e. equivalent to a purely velocity-encoding sequence) from a sagittal slice through the chamber of the phantom. The inflow rate of the phantom was varied between 0.007 and 6.85 mL min -1 (giving a theoretical fluid velocity range of 1 to 1000 μm s -1 , assuming laminar flow). Convection-MRI data were acquired in a cross-section across the phantom, without the vascular nulling preparation.
v enc for these acquisitions was varied between 1000 and 5000 μm s -1 , applied in separate acquisitions in the read and phase encoding directions.
Evaluation of the efficacy of vascular nulling
Phantom and in vivo experiments were performed to evaluate the ability of the convection-MRI sequence to null the signal from fluid flowing within tumor blood vessels. Two sets of images were acquired: the first without the vascular nulling (dual inversion) preparation, and the second with vascular nulling. Taking the ratio of images acquired with and without vascular nulling, referred to as the nulling ratio (n v ), enabled vascular volume to be approximately estimated (23) .
Influence of the assumed value of blood T 1 on vascular nulling in tumors
In a separate cohort of mice bearing SW1222 or LS174T tumors (n = 3 for each), the effect of varying t rec (equivalent to varying the assumed value of T 1,blood ) was investigated. Nulling ratio maps were produced in each tumor for 17 values of t rec , ranging from 100 to 5000 ms.
The average and standard deviation of the nulling ratio was estimated across the cohort and plotted as a function of t rec .
Estimation of apparent fluid pressure (P eff ) from convection-MRI data
IFP was estimated from velocity vector fields using Darcy's law:
v K P [2] x where K is the hydrostatic conductivity, v fluid velocity and P fluid pressure. To estimate P, velocity vector fields, measured using convection-MRI, were numerically integrated using a finite difference approach. To define absolute pressure, rather than relative changes in pressure, estimates were offset by the average value at the periphery of the tumor, with the assumption that the periphery of the tumor is in equilibrium with surrounding normal tissues (34) . We refer to this as the effective fluid pressure (P eff ). Thus, a boundary condition for the model was that the mean pressure at the periphery of the tumor is zero. Tumor blood vessels were modelled as randomly oriented cylinders. The radius of each vessel, r, was generated by randomly drawing from a distribution of vessel radii previously reported by Burrell et al (35) , which we fitted to an exponential probability distribution (p(r) = 0.15 exp(-70r)). The total blood vessel volume in each simulation was constrained to be within 10% of the average value (i.e. f v ranged from 7.2 to 8.8%). The pressure drop, P, across each vessel was fixed at 2 mm Hg mm -1 and blood viscosity, η, was fixed at 3.5×10 
where |v v | the magnitude of the blood velocity in the vessel, and α, β and γ are the angles of the vessel, relative to the x, y and z imaging gradient axes, respectively. The total signal from all blood vessels, for velocity-encoding gradients applied in the x-direction (the only direction evaluated in the simulations, for simplicity), was then
S 0,v was fixed at unity and relaxation effects were not modelled. To model the effect of fluid nulling in the vascular compartment a factor n v was introduced, which ranged from 0 and 1, representing zero to complete nulling. n v was calculated by the fractional volume of nulled fluid that replaced un-nulled fluid in blood vessels, at the end of the recovery time following the dual inversion pulses. This was given by
where a is the thickness of the imaging slice (1 mm) and selective inversion pulse (3 mm).
[6]
b is the thickness of the slice-Interstitial fluid velocity was varied between 1 and 100 μm s -1 and was directed along the xaxis, for simplicity. By analogy with the vascular signal, the signal from the interstitial compartment, for velocity-encoding gradients applied in the x direction, was
x andS 0,ees was fixed at unity. Simulated nulling of EES fluid was enc performed explicitly, with n ees ranging from 0 to 1. The total MR signal S was then given by [8] with f v  f ees  f ic  1 and S ic = 1.
1000 Monte Carlo iterations were performed, within each of which a different distribution of blood vessels (drawn from the parent distribution described above) was simulated. As a final step, Gaussian noise was added to each set of simulated data to give signal-to-noise characteristics comparable to those found in in vivo data. The phase of data simulated with velocity-encoding gradients applied in the x-direction was then estimated, converted into a velocity estimate, and compared with the simulated EES velocity.
Two sets of simulations were performed. Firstly, the effect of nulled fluid entering the interstitium was investigated by varying n ees between 0 (no nulling) and 1 (complete nulling).
Intravascular nulling, n v , was calculated according to Eq. 5, allowing the theoretical efficacy of vascular nulling to also be determined. In the second set of simulations, to ascertain the influence of un-nulled fluid in the vascular compartment on convection-MRI measurements, n v was explicitly scaled between 0 and 1, and n ees was fixed at 0.
Arterial spin labelling
Arterial spin labeling (ASL) data were acquired using a flow-sensitive alternating inversion recovery (FAIR) Look-Locker ASL sequence, with a single-slice spoiled gradient echo readout (36,37) (echo time, 1.18 ms; inversion time spacing, 110 ms; first inversion time, 2.3 ms; 50 inversion recovery readouts; 4 averages, all geometric parameters matched to the convection-MRI acquisition). FAIR-ASL does not require a labelling artery to be identified, and instead uses two acquisitions with different inversion preparations: the first, a global inversion pulse, inverts all spins; the second a localized, slice-selective pulse inverts spins within the tissue of interest (a 3 mm slice thickness was used here). The difference between these two signals can be used to measure perfusion, and here regional perfusion maps were calculated as described by Belle et al. (38) , with an assumed blood-partition constant of 0.9.
As for convection-MRI measurements, the T 1 longitudinal relaxation time of blood was assumed to be 1900 ms (39) . FAIR-ASL data were acquired in a single slice located in the same position as convection-MRI data.
Diffusion MRI
Diffusion MRI data were acquired using a fast spin-echo sequence with geometry matched to convection-MRI data. The sequence contained the following parameters: repetition time (TR), 1500 ms; echo train, 4; echo time spacing, 7.74 ms; 5 b-values (150, 300, 500, 750, 1050 s mm -2 , all applied in the slice-select direction). Diffusion-weighted (magnitude) data were fitted to a single exponential model of the form =− .
[9] 0 on a pixel-by-pixel basis, using a Bayesian maximum a posteriori approach that takes into account the Rician distribution of magnitude MRI data (40). b is the b-value associated with each diffusion-weighted acquisition, and S is the acquired signal magnitude for each pixel.
Maps of each fitted parameter (the apparent diffusion coefficient (ADC) and S 0 ) were generated.
Dynamic contrast-enhanced MRI
Gadolinium-DTPA (Magnevist, Bayer, Leverkusen, Germany) was prepared to a concentration of 0.2 mM (factor of 10 dilution) and transferred to a 50 mL Falcon tube. This 
Microvascular casting
Microvascular casting was performed for colocation of the convection-MRI and perfusion MRI with the tumor vasculature. Casting was performed immediately following MRI. Briefly, the heart was exposed and a blunted 25G butterfly cannula was inserted through the heart and into the ascending aorta. 10 mL of saline was injected through the cannula using a syringe driver (Harvard Instruments, MA, USA). Once the saline injection was complete, casting material (Microfil, Flowtech, Boston, USA) was injected via the same cannula at 60 mL hr 
Results
Evaluation of fluid velocity measurements in a flow phantom
The first experiment aimed to assess the sensitivity of the convection-MRI sequence to lowvelocity flow, using a simple flow phantom. Velocity measurements, with the vascular nulling preparation switched off and using a v enc of 1000, 2000 and 5000 μm s , theoretical velocity 1000 µm s -1 ), significant spatial wrapping was found in raw velocity encoded data, for the majority of v enc values used, so this data point was disregarded.
Whilst, for v enc ≥ 2000 µm s -1 , convection-MRI velocity measurements were significantly correlated with theoretical estimates, they displayed a slight overestimation (15 ± 23 %, based on the y-intercept of the regression line) (Figure 1c) . The minimum flow rate that could be measured before the signal approached the noise background level, was 0.07 mL min -1 (corresponding to a velocity of 20 m s -1 ).
Evaluation of vascular nulling in tumors
The convection-MRI sequence was next evaluated in vivo, using subcutaneous mouse tumor xenograft models (SW1222 and LS174T human colorectal carcinoma cell lines). Our Plotting the mean nulling ratio as a function of the assumed blood longitudinal relaxation time (T 1,blood ), from in vivo experiments in SW1222 tumors (n = 4), revealed a plateau centred at 1900 ms at which the signal decrease caused by nulling was maximal (Figure   2b ), suggesting that vasculaing nulling was most effective for an assumed T 1,blood = 1900 ms (and so was used throughout the remainder of the study).
Measurement of fluid velocity in tumors
Complete sets of convection-MRI data (i.e. with both vascular nulling and velocity encoding)
were next acquired in SW1222 and LS174T tumors (n = 6 for both) (Figs. 3a to n Table 1 ).
Numerical simulations of tumor fluid dynamics
Monte Carlo simulations of tumor fluid dynamics were performed using physiological measurements previously reported in the literature. ).
In the first set of simulations, it was found that n v was consistently greater than 99.9%, for each set of parameter values, suggesting that vascular nulling in this type of tumor is feasible. A fraction of the interstitial fluid was explicitly nulled to represent leakage of nulled fluid from the vasculature, and unintentional nulling of the interstitial fluid signal. Under these conditions, the accuracy of IFV measurements was unaffected by the nulling of interstitial fluid (Figure 4b ), but precision progressively decreased with increased nulling (evidenced by the increasing standard error shown in Figure 4b ). This loss of precision was caused by the decrease in signal-to-noise ratio resulting from the nulling, although the value of the simulated IFV had no influence on the magnitude of this effect.
In the second set of simulations, a progressive, incomplete nulling was imposed on the vascular fluid. It was found that both the accuracy and precision of IFV measurements became poorer as the fractional nulling of vascular fluid decreased (Figure 4c) . The mean relative error in velocity measurements was 15%, 50% and 115% for 95%, 80% and 50% vascular nulling, respectively. As shown in Figure 4c , incomplete vascular nulling introduced a progressive offset to velocity measurements, but the gradient of each line is constant.
Estimation of fluid pressure and comparison with a direct measurement with a pressure transducer
Convection-MRI provides measurements of fluid velocity vectors (i.e. with both direction and magnitude), from which we inferred an effective pressure (P eff ) using Darcy's Law of fluid flow in a permeable medium. Mean P eff from convection-MRI measurements was 13  2 mm On average, convection-MRI pressure measurements from the centre of tumors were 26% larger than those from the pressure transducer, and this over-estimation was larger at low IFP values. In these calculations, a fixed value was used for the hydrostatic conductivity (4.13×10 -8 cm 2 mm Hg -1 s -1 (4)).
Comparison of tumor blood flow and fluid velocity distributions
Next, the coupling of intravascular and interstitial flow was probed, in a set of experiments in which measurements of tumor fluid velocity were acquired with convection-MRI, alongside measurements of vascular perfusion from arterial spin labelling (ASL) MRI. These were accompanied by high resolution images blood vessels acquired ex vivo from vascular casts at high spatial resolution (6 μm), with micro-CT. 
The relationship between vascular perfusion and effective fluid pressure during tumor growth
The mechanisms that initiate and maintain raised IFP in tumors are of particular interest, and so we performed a further experiment that aimed to measure fluid velocity, effective fluid pressure and perfusion in tumors during growth from a small size (10 days following inoculation, defined as day 0), for a total of 10 days (Figure 7a) . We found no significant difference in the mean growth rates for SW1222 and LS174T tumors, which were measured from tumor volume estimates using high-resolution T 2 -weighted MRI. Investigating the relationship between each parameter and tumor volume revealed a significant inverse correlation between vascular perfusion and tumor volume, whilst fluid velocity and effective pressure were both positively correlated with tumor volume (p < 0.05, Figures 7b). As necrosis is generally more evident in LS174T tumors than in SW1222 tumors, it might be expected that the measured apparent diffusion coefficient (ADC) would be correspondingly larger; however, there was no significant difference between the two tumor types, which is consistent with our previous measurements (30) .
Assessment of response to therapy with a vascular disrupting agent
At the end of the growth experiment, and immediately following the final MRI measurement, we administered a single dose of the vascular disrupting agent CA4P (100 mg kg -1 ) to all mice. Previous studies have shown that this rapidly induces vascular occlusion and haemorrhage (41) , and a corresponding change in perfusion and IFP (42) . With this in mind,
we measured the change in perfusion, P eff and fluid velocity at 24 hours following dosing. As expected, tumor volume did not change significantly with CA4P dosing, whilst perfusion significantly decreased (p<0.01 in LS174T and p<0.05 in SW1222). Fluid velocity significantly increased in LS174T tumors (p < 0.05)) and P eff significantly decreased in SW1222 tumors (p < 0.05) (Figure 7c) . Tumor ADC significantly increased at 24 hours after dosing, in both tumor types, presumably due to the onset of necrosis (p < 0.05).
Discussion
We have proposed here a new technique named convection-MRI, which aims to measure low-velocity fluid flow in tumors, using phase contrast MRI, by first nulling the fast-flowing intravascular signal with a dual-inversion preparation. The aim of this study was to evaluate whether convection-MRI could directly measure the velocity of interstitial fluid. In order to achieve this a number of assumptions associated with the measurement would need to be validated, and we aimed to evaluate the most significant of these in this study. We then used convection-MRI to study low-velocity fluid flow in tumor xenograft models, which appeared to reveal macroscopic flow patterns that were consistent with the flow of fluid through the tumor interstitium, albeit at velocities greater than those normally associated with interstitial flow.
In tumor xenograft models of human colorectal cancer, we calculated mean fluid velocity ) will be associated with a greater uncertainty, due to the influence of noise. The presence of fluid velocities greater than 55 μm s -1 in our in vivo measurements is potentially due to contamination by faster-flowing vascular fluid. This therefore presents a challenge for the interpretation of convection-MRI data, as it cannot reasonably be claimed that velocity measurements are entirely interstitial in origin, nor that the entire range of interstitial flow velocities can be captured.
These observations were further explored through Monte Carlo simulations of a SW1222 tumors, which predicted vascular nulling of greater than 99.9%, for all sets of physiological parameters considered. They also showed that un-nulled vascular fluid can, in principle, be entirely replaced by nulled fluid within the recovery time t rec between vascular nulling and velocity encoding. In the simulations, straight tumor vessels were modelled, whilst real tumor vessels are likely to take more tortuous paths, thereby potentially explaining the disparity between our simulation results and the fluid velocities measured in vivo (43) . Sensitivity to these slower flowing components (and improved specificity towards interstitial flow) could therefore potentially be achieved by improving vascular nulling for slow-flowing blood, and increasing the acquisition v enc .
Whilst not an explicit component of the convection-MRI acquisition, in vivo estimates of blood volume were also derived by comparing nulled and un-nulled images. This analysis provided blood volume estimates that were greater than, but of the order of the microvascular density previously reported for these tumor types. Previous studies provide average blood volumes of between 9 (44) and 25% (30) for SW1222 and 8 (30) to 9% (45) for LS174T tumors, whereas we measured an average percentage vascular nulling of 18%
and 13% for SW1222 and LS174T tumors, respectively. The largest blood volume values were measured at the tumor periphery (of the order of 80%), where vessels tend to be larger and more concentrated (29) , which demonstrates the ability of convection-MRI to capture the spatial heterogeneity of tumor vasculature. These data could therefore act as a useful complement to the convection-MRI acquisition, although requires the acquisition of the additional un-nulled image.
Despite our velocity measurements being greater than those previously reported in the literature, we still found a significant correlation between P eff (derived from the spatial derivative of velocity measurements) and measurements of IFP measured directly with a pressure transducer, although with a 26% overestimation (Figure 5c) . We used Darcy's Law to quantify pressure from velocity vector fields, which is widely used in the modelling of fluid dynamics in biological tissue. It is valid for systems with a low Reynolds number which, in tumors, is typically much less than 1 (46) . When estimating absolute pressure from velocity vector fields, pressure boundary conditions are required, and here we assumed that the mean interstitial pressure at the periphery of tumors was maintained at atmospheric pressure (34) . Equally, we used a fixed value for the hydrostatic conductivity of tumor tissue, (48)). This variability, both in the magnitude and direction of velocity vectors, should be taken into account in future development or application work using the technique, although further work is required to determine if it is reflective of true physiological changes in interstitial and/or vascular transport over short timeframes. For example, it is well-known that tumor blood flow and oxygenation can change over short timeframes (49) (50) (51) , and this could potentially have similarly transient effects on interstitial flow.
We next probed the relationship between microvascular perfusion and interstitial fluid pressure, which has not been extensively studied, mainly due to a lack of available, noninvasive techniques. Our measurements, acquired over a period of ten days of tumor growth, revealed differences in the microenvironments of two colorectal tumor types. We found that perfusion on average decreased with tumor volume, whilst effective fluid pressure increased, which is in agreement with previous studies (20, 52) . Both low vascular perfusion and raised IFP can act as a barrier to drug delivery, our combined approach would allow these properties to be probed simultaneously and monitored longitudinally. Generally, LS174T tumors are more necrotic than SW1222 tumors, at 59 ± 4 % and 10 ± 3 %, respectively, in fully-grown tumors (53) , and which likely increases to these levels throughout tumor growth. Large regions of central necrosis occurs at 24 hours following dosing with CA4P (54). However, the presence of necrosis should not affect the convection-MRI acquisition (instead, it could be of interest to study further, to investigate the influence of necrosis on interstitial fluid pressure and drug delivery).
We have also shown here that ASL and convection-MRI, in combination, can be used to assess response to the vascular disrupting agent CA4P. The decrease in P eff that we observed in SW1222, and no significant change in LS174T tumors, is in agreement with the decrease or stasis found in other studies. It is of interest that SW1222 exhibited a minimal decrease in perfusion with CA4P treatment, compared with the response in LS174T, yet still exhibited a decrease in P eff and increase in ADC. This could be due to complex changes in tumor fluid dynamics, which could be of interest to further explore.
A number of studies have compared other imaging-based parameters with pressure transducer measurements of IFP, such as dynamic contrast enhanced MRI (8, 34) and/or diffusion MRI (55) . These have generally shown a correlation with IFP, but such relationships are not necessarily causal and could rely on associations with other aspects of tumor pathophysiology. However, the uptake of contrast agent has previously been shown to correlate with the uptake of chemotherapeutic drugs (56) and to probe interstitial transport and lymphatic drainage (57) , and convection-MRI could compliment these approaches via its ability to directly measure the flow of interstitial fluid within tumors. Some attempts have been made to quantify IFP from contrast agent studies (58, 59) , and a study comparing this approach and the convection-MRI technique would be useful. It is worth noting that our calculation of the nulling time within the convection-MRI signal model, assumed complete recovery of the longitudinal magnetisation within a practical acquisition recovery time.
However, a more accurate estimate could be used that takes into account for incomplete recovery of the longitudinal magnetisation. Simulations using the Bloch equations suggest that this effect introduces small (approximately 3%) error into the vascular nulling efficiency, but which could be utilised in future studies. 
